ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)

Heterologous prime/boost immunization with p53-based vaccines combined with toll-like receptor stimulation enhances tumor regression.

Hidenobu Ishizaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.